OMA Guidelines Bundle

Obesity Sleep 2026

Obesity Medicine Association OMA GUIDELINES App Bundle brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1544297

Contents of this Issue

Navigation

Page 4 of 7

Characteristics of Disordered Eating Patterns Topic Summary Binge eating disorder Occurs in up to 1 in 2 patients with severe obesity. Consider the presence of BED if patients report loss of control or marked distress about eating without purging. May be associated with ADHD. Bulimia nervosa Look for Russell sign and parotid swelling. Red flags: unexplained hypokalemia, metabolic alkalosis, or high serum amylase. Night eating syndrome Characterized by morning anorexia, evening hyperphagia, and insomnia. Associated with obesity, depression and daytime fatigue. Consider night eating in ref ractory obesity. Individuals are aware of their nighttime eating events. Weight stigma/ trauma History of bullying or restrictive dieting may suggest disordered eating. Empathetic and nonjudgemental communication are key. Weight stigma can trigger binge eating and avoidance of care. Other psychiatric comorbidities Common: depression, anxiety, PTSD, ADHD. Red flags: suicidal ideation or self-harm require urgent psychiatric referral. Sleep Related Eating Disorder (SRED) SRED is non-REM parasomnia characterized by recurrent episodes of involuntary eating during partial arousals f rom sleep, typically with reduced awareness and amnesia for the episodes.   ➤ Diagnostic Criteria • The diagnosis of OSA is established through objective sleep testing, with polysomnography serving as the gold standard for measuring the apnea-hypopnea index. Home sleep apnea testing is suitable for certain uncomplicated cases. The apnea-hypopnea index def ines OSA severity as mild (5–14.9 events/h), moderate (15–29.9 events/h), and severe (≥30 events/h). Clinical symptoms, such as excessive sleepiness and hypertension, are integrated with apnea-hypopnea index values to inform treatment decisions. Although emerging biomarkers, such as adipokine prof iles, are being studied, they are not yet part of standard diagnostic practice.

Articles in this issue

Archives of this issue

view archives of OMA Guidelines Bundle - Obesity Sleep 2026